Lecture 4.6 External Validity

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/27

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

28 Terms

1
New cards

_____ refers to the extent to which research findings can be applied to and taken as a measure of the target population.

Generalizability

2
New cards

Generalizability is largely determined by the selection of a(n) _____ and sufficiently _____ sample, as well as the overall thoroughness of the methodology.

Representative

Large

3
New cards

True/False:

The terms external validity and generalizability are used interchangeably.

True

4
New cards

Which of the following involves the study answering the question it claims to answer in the study sample?

A) Internal validity

B) External validity

A) Internal validity

5
New cards

Which of the following involves the absent or minimization of random and/or systematic errors?

A) Internal validity

B) External validity

A) Internal validity

6
New cards

Which of the following involves the study being generalizable to the population it claims to represent?

A) Internal validity

B) External validity

B) External validity

7
New cards

If the sample is not typical of the target population, there might be concerns on its _____.

Generalizability

8
New cards

Is the following scenario generalizable?

A new RCT on a statin drug included patients older than 18 years attempts to represent a target population of 18-93 year olds.

No

* Age distribution may not be well representative of that seen in real world patients

* Treatment may be ineffective and dangerous in geriatric patients

9
New cards

One solution for poor generalizability is _____ in which results are reported for each level.

Subgroup analyses

10
New cards

Which of the following is NOT a problem with subgroup analyses?

A) Smaller sample sizes in each subgroup

B) Studies are not "powered" for subgroup analyses

C) Randomization is not maintained in subgroups

D) Higher chances for confounding and bias

E) Increased randomization of patients in subgroups

E) Increased randomization of patients in subgroups

* No randomization into subgroups

11
New cards

When evaluating generalizability, researchers should list the _____ between the study sample and the clinical population, then assess the _____ of each one.

Differences

Relevance

12
New cards

Which of the following would NOT be something to consider for when evaluating generalizability?

A) Demographics

B) Patient consent status

C) Clinical characteristics

D) Regional and temporal differences

B) Patient consent status

13
New cards

Is the following scenario generalizable?

A new RCT on the pharmacological treatment of benign prostate hyperplasia (BPH) has a sample of 300 males within the range of 55-83 year olds, all residing in the state of Florida

Yes

* Sample looks reasonable

* BPH ONLY affects men so sample and population would be the same (includes majority of target patients)

* Differences with other populations EXIST, but may not alter the results

14
New cards

Is the following scenario generalizable?

A new survey on use of contraceptives in front of UF campus.

No

* Mainly college students

* Higher education

* Age range NOT representative

* Not generalizable BEYOND college students

15
New cards

Is the following scenario generalizable?

A new RCT on the efficacy of leukemia treatment in Finland with a sample of 200 Finnish patients (45% male) attempting to represent a population in Florida

No

* Race, socioeconomic status, education, diet, climate, and healthcare system between Finland and FL are very different

16
New cards

Which of the following consists of a SMALLER number of patients with MINOR variation in demographic and clinical parameters?

A) Explanatory (narrow) studies

B) Pragmatic (broad) studies

A) Explanatory (narrow) studies

* Specialized/controlled conditions

17
New cards

Which of the following consists of a LARGER number of patients with MORE variation in demographic and clinical parameters?

A) Explanatory (narrow) studies

B) Pragmatic (broad) studies

B) Pragmatic (broad) studies

* Normal conditions

18
New cards

Which of the following has high EXTERNAL validity (good generalizability)?

A) Explanatory (narrow) studies

B) Pragmatic (broad) studies

B) Pragmatic (broad) studies

19
New cards

Which of the following has a simple design?

A) Explanatory (narrow) studies

B) Pragmatic (broad) studies

B) Pragmatic (broad) studies

20
New cards

Which of the following occurs in mainly Phase IV trials?

A) Explanatory (narrow) studies

B) Pragmatic (broad) studies

B) Pragmatic (broad) studies

21
New cards

Which of the following occurs in mainly Phase II or III trials?

A) Explanatory (narrow) studies

B) Pragmatic (broad) studies

A) Explanatory (narrow) studies

22
New cards

Which of the following occurs has high INTERNAL validity?

A) Explanatory (narrow) studies

B) Pragmatic (broad) studies

A) Explanatory (narrow) studies

23
New cards

Which of the following occurs has a sophisticated design?

A) Explanatory (narrow) studies

B) Pragmatic (broad) studies

A) Explanatory (narrow) studies

24
New cards

Which of the following is narrow?

A) Explanatory studies

B) Pragmatic studies

A) Explanatory studies

25
New cards

Which of the following is broad?

A) Explanatory studies

B) Pragmatic studies

B) Pragmatic studies

26
New cards

Which is more important?

A) Explanatory studies

B) Pragmatic studies

C) Both are equally important

C) Both are equally important

27
New cards

If a study is not valid _____, the question of _____ is not relevant.

Internally

Generalizability

28
New cards

If a study IS internally valid, but not applicable to the population, its value is _____.

Limited